Shanghai Runda Medical Technology Co

Shanghai Runda Medical Technology Co Financing Cash Flow

The Net Financing Cash Flow of Shanghai Runda Medical Technology Co (603108.SS) as of Nov 3, 2026 is 92.30 M CNY. In the previous year, Net Financing Cash Flow was -334.90 M CNY — a change of -127.56% (higher).

Financing Cash Flow

92.30 MCNY

YoY

-127.56%

Last updated:

Net Financing Cash Flow of Shanghai Runda Medical Technology Co is 2024 92.30 M CNY. Net Financing Cash Flow of Shanghai Runda Medical Technology Co was 2023 -334.90 M CNY. It decreases by -127.56% higher compared to the previous year.

The Shanghai Runda Medical Technology Co Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2017
1.45 B CNY
Jan 1, 2018
-427.81 M CNY
Jan 1, 2019
258.47 M CNY
Jan 1, 2020
805.81 M CNY
Jan 1, 2021
94.95 M CNY
Jan 1, 2022
488.13 M CNY
Jan 1, 2023
-334.90 M CNY
Jan 1, 2024
92.30 M CNY
The Shanghai Runda Medical Technology Co Financing Cash Flow history
YEARFinancing Cash FlowYoY
92.30 MCNY-127.56%
-334.90 MCNY-168.61%
488.13 MCNY+414.10%
94.95 MCNY-88.22%
805.81 MCNY+211.76%
258.47 MCNY-160.42%
-427.81 MCNY-129.60%
1.45 BCNY-13.39%
1.67 BCNY+196.67%
562.37 MCNY+1,373.46%
38.17 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Runda Medical Technology Co Stock analysis

What does Shanghai Runda Medical Technology Co do? Shanghai Runda Medical Technology Co., Ltd. generates revenue through the wholesale distribution of surgical and medical instruments, apparatus, and equipment within the domestic market. The company offers integrated services including product portfolio options, professional application services, logistics warehousing distribution systems, and technical support. Its customers include healthcare providers and medical institutions that require surgical tools and equipment. The firm's business model focuses on domestic sales with a workforce of 3,499 full-time employees managing these operations. The company's primary revenue streams come from the distribution of medical instruments and equipment, supported by its comprehensive service offerings. It provides sales support and customer channel management to facilitate transactions with its clients. The firm's domestic market focus ensures that its services are tailored to the needs of Chinese healthcare facilities and institutions. Shanghai Runda's business is structured around the wholesale distribution of medical products, with additional value-added services such as technical support and logistics management. The company's integrated approach combines product distribution with application services, enhancing its market position in the domestic healthcare sector. Shanghai Runda Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Runda Medical Technology Co stock

Net Financing Cash Flow of Shanghai Runda Medical Technology Co is 92.30 M CNY in 2024.

Net Financing Cash Flow of Shanghai Runda Medical Technology Co changed from -334.90 M CNY to 92.30 M CNY, representing a -127.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Shanghai Runda Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Shanghai Runda Medical Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Shanghai Runda Medical Technology Co

All Key Metrics — Shanghai Runda Medical Technology Co